KR20010012952A - 화상과 여러 피부 외상의 치료를 위한 수단 및 조성물 - Google Patents
화상과 여러 피부 외상의 치료를 위한 수단 및 조성물 Download PDFInfo
- Publication number
- KR20010012952A KR20010012952A KR1019997010922A KR19997010922A KR20010012952A KR 20010012952 A KR20010012952 A KR 20010012952A KR 1019997010922 A KR1019997010922 A KR 1019997010922A KR 19997010922 A KR19997010922 A KR 19997010922A KR 20010012952 A KR20010012952 A KR 20010012952A
- Authority
- KR
- South Korea
- Prior art keywords
- tissue
- necrotic
- skin
- treatment
- debridement
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 title claims description 40
- 208000014674 injury Diseases 0.000 title claims description 19
- 230000008733 trauma Effects 0.000 title claims description 16
- 238000001804 debridement Methods 0.000 claims abstract description 57
- 230000000472 traumatic effect Effects 0.000 claims abstract description 7
- 238000002203 pretreatment Methods 0.000 claims abstract description 5
- 230000001338 necrotic effect Effects 0.000 claims description 60
- 210000003491 skin Anatomy 0.000 claims description 48
- 239000010410 layer Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 30
- 230000000740 bleeding effect Effects 0.000 claims description 27
- 239000011159 matrix material Substances 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 230000017074 necrotic cell death Effects 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 19
- 230000003902 lesion Effects 0.000 claims description 18
- 210000004207 dermis Anatomy 0.000 claims description 16
- 102000008186 Collagen Human genes 0.000 claims description 15
- 108010035532 Collagen Proteins 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 229920001436 collagen Polymers 0.000 claims description 15
- 230000006378 damage Effects 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 230000035755 proliferation Effects 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 11
- 239000011229 interlayer Substances 0.000 claims description 10
- 230000001681 protective effect Effects 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 8
- 239000007952 growth promoter Substances 0.000 claims description 7
- 108010004032 Bromelains Proteins 0.000 claims description 6
- 235000019835 bromelain Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000009792 diffusion process Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 108090000886 Ananain Proteins 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 108010001587 escharase Proteins 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 2
- -1 Debridase Proteins 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000000122 growth hormone Substances 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229960004533 streptodornase Drugs 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims 2
- 102000029816 Collagenase Human genes 0.000 claims 1
- 108060005980 Collagenase Proteins 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
- 229960002424 collagenase Drugs 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 230000002797 proteolythic effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 82
- 206010051814 Eschar Diseases 0.000 description 32
- 231100000333 eschar Toxicity 0.000 description 32
- 206010028851 Necrosis Diseases 0.000 description 18
- 210000004204 blood vessel Anatomy 0.000 description 13
- 238000001356 surgical procedure Methods 0.000 description 13
- 238000002054 transplantation Methods 0.000 description 12
- 231100000241 scar Toxicity 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 206010040047 Sepsis Diseases 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 230000002269 spontaneous effect Effects 0.000 description 8
- 206010063560 Excessive granulation tissue Diseases 0.000 description 7
- 210000001126 granulation tissue Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 208000032544 Cicatrix Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 230000037387 scars Effects 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000011109 contamination Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000000887 hydrating effect Effects 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 108010022069 sultilains Proteins 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000031729 Bacteremia Diseases 0.000 description 2
- 206010006802 Burns second degree Diseases 0.000 description 2
- 206010006803 Burns third degree Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000234671 Ananas Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 208000006440 Open Bite Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 108010086613 Streptodornase and Streptokinase Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 201000005008 bacterial sepsis Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229940109357 desoxyribonuclease Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011273 incision biopsy Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002154 ionophoretic effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 108010016297 plasmin drug combination deoxyribonuclease Proteins 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940115037 santyl Drugs 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229950010549 sutilains Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F15/00—Auxiliary appliances for wound dressings; Dispensing containers for dressings or bandages
- A61F15/001—Packages or dispensers for bandages, cotton balls, drapes, dressings, gauze, gowns, sheets, sponges, swabsticks or towels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL120909 | 1997-05-26 | ||
| IL12090997A IL120909A0 (en) | 1997-05-26 | 1997-05-26 | Compositions and means for the treatment of burns and other cutaneous traumas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010012952A true KR20010012952A (ko) | 2001-02-26 |
Family
ID=11070172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997010922A KR20010012952A (ko) | 1997-05-26 | 1998-05-25 | 화상과 여러 피부 외상의 치료를 위한 수단 및 조성물 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0983085A2 (fr) |
| JP (1) | JP2002501525A (fr) |
| KR (1) | KR20010012952A (fr) |
| AU (1) | AU7448198A (fr) |
| IL (1) | IL120909A0 (fr) |
| WO (1) | WO1998053850A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137689A0 (en) * | 2000-08-03 | 2001-10-31 | L R Res & Dev Ltd | System for enhanced chemical debridement |
| AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
| AU2003222418B2 (en) * | 2002-04-23 | 2008-10-23 | Mediwound, Ltd. | Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome |
| WO2004069147A2 (fr) * | 2003-02-03 | 2004-08-19 | Mediwound Ltd. | Systeme de parage chimique ameliore |
| US20060233783A1 (en) * | 2003-04-09 | 2006-10-19 | Gomez Torres Harold A | Topical composition in the form of a gel for treating skin burns |
| EP1773379A4 (fr) * | 2004-07-13 | 2009-07-15 | Mediwound Ltd | Compositions et methodes de cicatrisation pour lesions dermatologiques |
| MX2011003557A (es) * | 2008-10-02 | 2011-09-01 | Lrr & D Ltd | Vendas para heridas con capa de interfaz. |
| AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
| IL256675A (en) * | 2017-12-31 | 2018-02-28 | Technion Res & Development Found Ltd | Methods and preparations for the prevention and treatment of pressure sores |
| US10883084B2 (en) | 2018-10-05 | 2021-01-05 | Xenotherapeutics, Inc. | Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same |
| WO2020072982A1 (fr) | 2018-10-05 | 2020-04-09 | Xenotherapeutics, Inc. | Produits et procédés de xénotransplantation |
| MX2021011709A (es) | 2019-03-25 | 2022-01-06 | Xenotherapeutics Inc | Celulas, tejidos y organos personalizados para trasplante de un donante humanizado, adaptado, designado libre de patogenos (no humano) y metodos y productos relacionados con estos. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0040862A1 (fr) * | 1979-01-11 | 1981-12-02 | Key Pharmaceuticals, Inc. | Matrice pour brûlures, procédé pour sa préparation et appareil de dosage comprenant cette matrice |
| US4668228A (en) * | 1985-03-12 | 1987-05-26 | Johnson & Johnson Products, Inc. | Debriding tape |
| US4784653A (en) * | 1987-06-22 | 1988-11-15 | Johnson & Johnson Patient Care, Inc. | Absorbent adhesive dressing |
| US5296222A (en) * | 1989-02-23 | 1994-03-22 | University Of Utah | Percutaneous drug delivery system |
| EP0498532A1 (fr) * | 1991-01-10 | 1992-08-12 | E.R. SQUIBB & SONS, INC. | Poudre pour le débridement des tissus nécropés contenant une enzyme protéolytique |
| AU4104093A (en) * | 1992-04-20 | 1993-11-18 | Rufeld, Inc. | Method and compositions for treatment of pyonecrotic processes |
| AU1939895A (en) * | 1994-03-01 | 1995-09-18 | E.R. Squibb & Sons, Inc. | Enzymatic debridement compositions and methods |
-
1997
- 1997-05-26 IL IL12090997A patent/IL120909A0/xx unknown
-
1998
- 1998-05-25 KR KR1019997010922A patent/KR20010012952A/ko not_active Application Discontinuation
- 1998-05-25 AU AU74481/98A patent/AU7448198A/en not_active Abandoned
- 1998-05-25 WO PCT/IL1998/000237 patent/WO1998053850A2/fr not_active Application Discontinuation
- 1998-05-25 EP EP98921713A patent/EP0983085A2/fr not_active Withdrawn
- 1998-05-25 JP JP50043299A patent/JP2002501525A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998053850A3 (fr) | 1999-08-12 |
| EP0983085A2 (fr) | 2000-03-08 |
| IL120909A0 (en) | 1997-09-30 |
| WO1998053850A2 (fr) | 1998-12-03 |
| AU7448198A (en) | 1998-12-30 |
| JP2002501525A (ja) | 2002-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han | Innovations and advances in wound healing | |
| Venturi et al. | Mechanisms and clinical applications of the vacuum-assisted closure (VAC) device: a review | |
| Attinger et al. | Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants | |
| US7128719B2 (en) | System for enhanced chemical debridement | |
| JPH09504719A (ja) | 止血パッチ | |
| KR20010012952A (ko) | 화상과 여러 피부 외상의 치료를 위한 수단 및 조성물 | |
| RU2106154C1 (ru) | Перевязочный материал | |
| JP7378486B2 (ja) | 医療用接着剤及びその調製方法、その用途 | |
| Schumacher et al. | Free skin grafting | |
| Cai et al. | Analysis of the Curative Effect and Influencing Factors of Collagen Sponge Combined with Autologous Skin Graft in the Treatment of Deep Burn Patients | |
| Arámbula et al. | Frozen human epidermal allogeneic cultures promote rapid healing of facial dermabrasion wounds | |
| Jones | Debridement of diabetic foot lesions | |
| CA1294875C (fr) | Extraits de cellules epidermiques et methode pour favoriser la cicatrisation des plaies et la regeneration de l'epiderme | |
| Price et al. | Skin repair technology | |
| Pollock et al. | Principles of wound management | |
| MILLER et al. | HEALING OF SECOND DEGREE BURNS: Comparison of Effects of Early Application of Horaografts and Coverage with Tape | |
| Altmeyer et al. | Wound healing and skin physiology | |
| CA2456814A1 (fr) | Utilisation d'extraits de larves de mouches pour traiter des plaies | |
| US20030072750A1 (en) | Compositions and means for the treatment of burns and other cutaneous traumas | |
| Prystowsky et al. | Artificial skin (integra” dermal regeneration template) for closure of lower extremity wounds | |
| Curreri et al. | Safety and efficacy of a new synthetic burn dressing: a multicenter study | |
| RU2803946C1 (ru) | Способ лечения длительно незаживающих ран | |
| Iorio et al. | Soft tissue reconstructive options for the ulcerated or gangrenous diabetic foot | |
| LARSON | Closure of the burn wound | |
| Burd | Burn Dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |